Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Cryobanks and DSI sign procurement agreement for umbilical cord blood
Under the agreement Donor Services of Indiana (DSI) will collect cord blood on behalf of Cryobanks International (CI) for donation and private storage from mothers in seven Fort
Under the agreement Donor Services of Indiana (DSI) will collect cord blood on behalf of Cryobanks International (CI) for donation and private storage from mothers in seven Fort
Northstar has named Brian Dow as its new CFO and vice president of finance, effective January 1, 2009. Mr Dow brings over 16 years of financial management and
The two vitrification products that Vitrolife has obtained approval for are RapidVit Cleave och RapidWarm Cleave. These two products, and two further vitrification products, RapidVit Blast och RapidWarm
Orexigen has retained an executive search firm to assist it in finding a new, permanent CEO. In addition, Anthony McKinney, the company’s chief business officer, and Frank Bymaster,
In addition, it has removed Mr Hermelin as the chairman of the board and as the CEO of the company. Mr Hermelin is expected to remain as a
Following the restructuring, the company will have approximately 120 employees and expects to reduce future net losses and cash burn by approximately $4 million annually. The company expects
Neutekbio’s technologies and products complement perfectly Biomonitor’s current offerings to physicians and clinics involved in treatment of patients with multiple sclerosis, rheumatoid arthritis and Crohn’s disease worldwide.
The international, double-blind, placebo-controlled safety and efficacy study of Gattex is known as STEPS. STEPS will enroll approximately 86 parenteral nutrition (PN)-dependent short-bowl syndrome (SBS) patients in North
Results of this fully compliant ICH-GCP conducted study indicate that the MetControl metformin chewing gum and traditional metformin tablets are bioequivalent in respect of both the rate and
The randomized, controlled trial will compare farletuzumab plus paclitaxel with a placebo plus paclitaxel. The primary objective of the study is to assess the efficacy of farletuzumab as